USJ-11152-71078
3 vaccinations
5 coded responses
35 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 951 / CA
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-01
Dose 1 — Moderna
-
2021-01-04
Registered in v-safe
-
2021-01-04
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Scheduled COVID testMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-04
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-07
- 2021-01-08
- 2021-01-15
- 2021-01-22
-
2021-01-29
Dose 2 — Moderna
- 2021-01-29
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-01-30
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Eye swelling — Feeling: Fair · Site: Pain · Headache · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Swelling under eye where had dermal filler 16 months agoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-01
- 2021-02-02
-
2021-02-03
Survey response — days 1–6 daily, dose 2MedDRA: Night sweats — Feeling: GoodFree text: Sweating through the nightMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-03
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Hot flush — Feeling: GoodFree text: Hot flashes during sleepMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Call successfulParticipant prefers to complete VAERS report online
-
2021-02-05
Survey response — day 7, dose 2MedDRA: Night sweats — Feeling: Good · Fatigue or tirednessFree text: Night sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-04-30
- 2021-07-30
-
2021-10-22
Dose 3 — Moderna
-
2021-10-23
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-24
- 2021-10-25
- 2021-10-26
- 2021-10-27
- 2021-10-28
- 2021-10-31
- 2021-11-05
- 2021-11-12
- 2021-11-21
- 2021-11-26
- 2021-12-03
- 2022-01-21
- 2022-04-22
- 2022-10-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-01 | Moderna | |
| 2 | 2021-01-29 | Moderna | |
| 3 | 2021-10-22 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-04 | Successful | Participant prefers to complete VAERS report online |
| 2021-01-30 | Successful | Reported to VAERS during previous contact from GDIT |
| 2021-01-31 | Successful 2021-02-04 |
Participant prefers to complete VAERS report online |
Free text
Release 1 — days 1–6 daily, dose 1
Healthcare visit (other): Scheduled COVID test
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Swelling under eye where had dermal filler 16 months ago
Systemic reaction (other): Sweating through the night
Systemic reaction (other): Hot flashes during sleep
Release 3 — day 7, dose 2
Systemic reaction (other): Night sweats
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | No adverse event | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | ○ | ○ | ○ |
| SRO | Eye swelling | ✓ | ✓ | ✓ |
| SRO | Hot flush | ✓ | ✓ | ✓ |
| SRO | Night sweats | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release